Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
Stage-Specific Regulation of Oligodendrocyte Development by Wnt/β-Catenin Signaling.
[Pregnancy and delivery in women with multiple sclerosis: a retrospective analysis.]
How embodied is action language? Neurological evidence from motor diseases.
[Fampridine and multiple sclerosis.]
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression.
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
A case of chronic inflammatory demyelinating polyneuropathy with reversible alternating diaphragmatic paralysis: case study.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Loss of branched o-mannosyl glycans in astrocytes accelerates remyelination.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Muscle oxygen consumption by NIRS and mobility in multiple sclerosis patients.
The immunomodulatory oligodendrocyte.
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis.
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.

Pages